François A. Lemonnier

Overview

Best Publications

• Endocytosis of major histocompatibility complex class I molecules is induced by the HIV-1 Nef protein

  O Schwartz;V Maréchal;S Le Gall;F Lemonnier

  1439
  Citations

• Differential Requirements for Survival and Proliferation of CD8 Naïve or Memory T Cells

  Corinne Tanchot;François A. Lemonnier;François A. Lemonnier;Beatrice Pérarnau;Beatrice Pérarnau;Antonio A. Freitas;Antonio A. Freitas

  1287
  Citations

• Persistence of Memory CD8 T Cells in MHC Class I-Deficient Mice

  Kaja Murali-Krishna;Lisa L. Lau;Suryaprakash Sambhara;Francois Lemonnier

  970
  Citations

• HLA-A2.1–restricted Education and Cytolytic Activity of CD8+ T Lymphocytes from β2 Microglobulin (β2m) HLA-A2.1 Monochain Transgenic H-2Db β2m Double Knockout Mice

  Steve Pascolo;Nathalie Bervas;Jan M. Ure;Austin G. Smith

  811
  Citations

• An invariant T cell receptor α chain defines a novel TAP-independent major histocompatibility complex class Ib-restricted α/β T cell subpopulation in mammals

  Florence Tilloy;Emmanuel Treiner;Se Ho Park;Corinne Garcia

  676
  Citations

• Exosomes as Potent Cell-Free Peptide-Based Vaccine. I. Dendritic Cell-Derived Exosomes Transfer Functional MHC Class I/Peptide Complexes to Dendritic Cells

  Fabrice André;Nathalie Chaput;Nöel E. C. Schartz;Caroline Flament

  595
  Citations

• IDH2 mutations are frequent in angioimmunoblastic T-cell lymphoma.

  Rob A. Cairns;Javeed Iqbal;François Lemonnier;Can Kucuk

  564
  Citations

• Recurrent TET2 mutations in peripheral T-cell lymphomas correlate with TFH-like features and adverse clinical parameters.

  François Lemonnier;François Lemonnier;Lucile Couronné;Marie Parrens;Jean-Philippe Jaïs

  529
  Citations

• Direct Assessment of MHC Class I Binding by Seven Ly49 Inhibitory NK Cell Receptors

  Thomas Hanke;Hisao Takizawa;Christopher W McMahon;Dirk H Busch

  394
  Citations

• Exosomes as Potent Cell-Free Peptide-Based Vaccine. II. Exosomes in CpG Adjuvants Efficiently Prime Naive Tc1 Lymphocytes Leading to Tumor Rejection

  Nathalie Chaput;Nöel E. C. Schartz;Fabrice André;Julien Taïeb

  354
  Citations

• Activating mutations in genes related to TCR signaling in angioimmunoblastic and other follicular helper T-cell-derived lymphomas

  David Vallois;Maria Pamela D. Dobay;Ryan D. Morin;Ryan D. Morin;François Lemonnier

  325
  Citations

• Sustained Progression-Free Survival Benefit of Rituximab Maintenance in Patients With Follicular Lymphoma: Long-Term Results of the PRIMA Study

  Emmanuel Bachy;John F. Seymour;Pierre Feugier;Fritz Offner

  277
  Citations

• Single H2Kb, H2Db and double H2KbDb knockout mice: peripheral CD8+ T cell repertoire and anti-lymphocytic choriomeningitis virus cytolytic responses.

  Béatrice Pérarnau;Marie Françoise Saron;Bernardo Reina San Martin;Nathalie Bervas

  274
  Citations

• Genetic drivers of oncogenic pathways in molecular subgroups of peripheral T-cell lymphoma

  Tayla B. Heavican;Alyssa Bouska;Jiayu Yu;Waseem Lone

  270
  Citations

• Chemoimmunotherapy of Tumors: Cyclophosphamide Synergizes with Exosome Based Vaccines

  Julien Taieb;Nathalie Chaput;Noël Schartz;Stéphan Roux

  264
  Citations

• H-2 class I knockout, HLA-A2.1-transgenic mice: a versatile animal model for preclinical evaluation of antitumor immunotherapeutic strategies

  Hüseyin Firat;Francisco Garcia-Pons;Sophie Tourdot;Steve Pascolo

  242
  Citations

• Integrative clinicopathological and molecular analyses of angioimmunoblastic T-cell lymphoma and other nodal lymphomas of follicular helper T-cell origin.

  Maria Pamela Dobay;Francois Lemonnier;Edoardo Missiaglia;Christian Bastard

  232
  Citations

• A mouse model of human adaptive immune functions: HLA-A2.1-/HLA-DR1-transgenic H-2 class I-/class II-knockout mice.

  Anthony Pajot;Marie-Louise Michel;Nicolas Fazilleau;Véronique Pancré

  217
  Citations

• A general strategy to enhance immunogenicity of low-affinity HLA-A2.1-associated peptides: implication in the identification of cryptic tumor epitopes

  Sophie Tourdot;Antonio Scardino;Eleanna Saloustrou;David A. Gross

  216
  Citations

• Natural killer cell education in mice with single or multiple major histocompatibility complex class I molecules

  Sofia Johansson;Maria Johansson;Eleftheria Rosmaraki;Gustaf Vahlne

  204
  Citations

• Mutant IDH1 Downregulates ATM and Alters DNA Repair and Sensitivity to DNA Damage Independent of TET2.

  Satoshi Inoue;Satoshi Inoue;Wanda Y. Li;Wanda Y. Li;Alan Tseng;Alan Tseng;Alan Tseng;Isabel Beerman;Isabel Beerman

  194
  Citations

• High vaccination efficiency of low-affinity epitopes in antitumor immunotherapy

  David-Alexandre Gross;Stéphanie Graff-Dubois;Paule Opolon;Sébastien Cornet

  188
  Citations

• Identification of vaccinia virus epitope-specific HLA-A*0201-restricted T cells and comparative analysis of smallpox vaccines.

  Ingo Drexler;Caroline Staib;Wolfgang Kastenmüller;Stefan Stevanović

  184
  Citations

• Major histocompatibility complex (MHC) class I KbDb −/− deficient mice possess functional CD8+ T cells and natural killer cells

  Yulia Vugmeyster;Rickard Glas;Béatrice Pérarnau;François A. Lemonnier

  179
  Citations

• Introduction of exogenous antigens into the MHC class I processing and presentation pathway by Drosophila antennapedia homeodomain primes cytotoxic T cells in vivo.

  M P Schutze-Redelmeier;H Gournier;F Garcia-Pons;M Moussa

  177
  Citations

• HER-2/neu and hTERT cryptic epitopes as novel targets for broad spectrum tumor immunotherapy.

  Antonio Scardino;David Alexandre Gross;Pedro Alves;Joachim L. Schultze

  176
  Citations

• Immunogenicity of a human immunodeficiency virus (HIV) polytope vaccine containing multiple HLA A2 HIV CD8(+) cytotoxic T-cell epitopes.

  T. Woodberry;J. Gardner;Luis A. Mateo;D. Eisen

  159
  Citations

• Cytolytic thymus-derived lymphocytes specific for allogeneic stimulator cells crossreact with chemically modified syngeneic cells.

  Francois Lemonnier;Steven J. Burakoff;Ronald N. Germain;Baruj Benacerraf

  158
  Citations

• An HLA-A2 polyepitope vaccine for melanoma immunotherapy.

  Luis Mateo;Joy Gardner;Qiyuan Chen;Christopher Schmidt

  158
  Citations

• Treatment with 5-azacytidine induces a sustained response in patients with angioimmunoblastic T-cell lymphoma.

  François Lemonnier;François Lemonnier;Jehan Dupuis;Pierre Sujobert;Olivier Tournillhac

  153
  Citations

• ALK as a novel lymphoma-associated tumor antigen: identification of 2 HLA-A2.1-restricted CD8+ T-cell epitopes.

  Lorena Passoni;Antonio Scardino;Carla Bertazzoli;Barbara Gallo

  137
  Citations

• Identification of naturally processed HLA-A2--restricted proinsulin epitopes by reverse immunology.

  Yousra Hassainya;Francisco Garcia-Pons;Roland Kratzer;Vivian Lindo

  123
  Citations

• Gene alterations in epigenetic modifiers and JAK-STAT signaling are frequent in breast implant–associated ALCL

  Camille Laurent;Alina Nicolae;Cécile Laurent;Fabien Le Bras

  122
  Citations

• Cutting Edge: Expression of Functional CD94/NKG2A Inhibitory Receptors on Fetal NK1.1+Ly-49− Cells: A Possible Mechanism of Tolerance During NK Cell Development

  P. V. Sivakumar;A. Gunturi;M. Salcedo;J. D. Schatzle

  119
  Citations

• Quantification by flow cytofluorimetry of HLA class I molecules at the surface of murine cells transformed by cloned HLA genes

  Philippe P. Le Bouteiller;Zohair Mishal;François A. Lemonnier;François M. Kourilsky

  114
  Citations